SRNE 株価推移チャート
SRNE 収入
Sorrento Therapeutics Inc
$0
-11.11%
$0
終値： May 07, 16:00:00 GMT-4
$0
0%
$0
アフターマーケット：May 07, 20:00:00 GMT-4
戻る
Sorrento Therapeutics Inc (SRNE) 収入
主要データ
前終値
$0.0009
始値
$0.0008
当日レンジ
$0.0008 - $0.0008
52週レンジ
$0.0002 - $0.0985
取引高
19.5K
平均取引高
370.7K
配当利回り
--
1株当たり利益(TTM)
-1.87
時価総額
$441.0K
SRNEとは何ですか？
Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The company is headquartered in San Diego, California and currently employs 949 full-time employees. The company went IPO on 2007-01-19. The firm is engaged in developing a portfolio of next-generation treatments for cancer, infectious diseases and pain. The company is also developing Resiniferatoxin (RTX), a naturally occurring non-opioid ultra-potent transient receptor potential vanilloid-1 agonist. The Company’s proprietary fully human G-MAB antibody library and ACEA small molecule library are the pipeline of new solutions for cancer. Its diagnostics platforms include the COVIMARK lateral flow antigen test and the VIREX platform.
